IPSC - Century Therapeutics GAAP EPS of -$0.53 revenue of $1.72M May, 11 2023 09:56 AM Century Therapeutics Inc. 2023-05-11 09:56:04 ET Century Therapeutics press release ( NASDAQ: IPSC ): Q1 GAAP EPS of -$0.53. Revenue of $1.72M (+63.8% Y/Y). For further details see: Century Therapeutics GAAP EPS of -$0.53, revenue of $1.72M